Lombard Odier Asset Management (Switzerland)’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
FP
TP
Lombard Odier Asset Management (Switzerland)'s MRNA Position: Q2 2023 in Review
Lombard Odier Asset Management (Switzerland) sold out of Moderna (MRNA) in Q2 2023, closing a stake of 2,016 shares — an estimated $310K sold.
Lombard Odier Asset Management (Switzerland) first reported a position in MRNA in Q1 2021 and held it in 5 quarters. The position peaked at $16.7M in Q1 2021. 967 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.
- Lombard Odier Asset Management (Switzerland) reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
- Lombard Odier Asset Management (Switzerland) sold 2,016 Moderna shares in Q2 2023, an estimated $310K.
- Lombard Odier Asset Management (Switzerland) first reported a position in Moderna in Q1 2021 and held it in 5 quarters.
- Lombard Odier Asset Management (Switzerland)'s Moderna position peaked at $16.7M in Q1 2021.
- 967 funds tracked by Wall St. Rank held Moderna as of Q2 2023.
Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 14 Aug 2023.